← Search

Data · dataset · 2015

No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement

Listed in LSHTM Data Compass

Supplementary data published as part of a comparison of the cancer risk of cladribine and other disease-modifying drugs (DMDs) in trials containing people with relapsing multiple sclerosis (pwRMS).

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75%
Provenance · 1 source records, 9 field assertions
SourceKeyLast seenRaw
LSHTM Data Compassoai:datacompass.lshtm.ac.uk:8811 d agoJSON v1
FieldAssertionExtractorEvidence
concepts[disease].local:disease:cancerenrichment · lshtm ac ukkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · lshtm ac ukconnector:lshtm_ac_uk@1.0.0
concepts[field].local:field:humanitiesmapping · lshtm ac ukconnector:lshtm_ac_uk@1.0.0
concepts[field].local:field:life-sciencesmapping · lshtm ac ukconnector:lshtm_ac_uk@1.0.0
concepts[field].local:field:medicine-healthmapping · lshtm ac ukconnector:lshtm_ac_uk@1.0.0
concepts[field].local:field:social-sciencemapping · lshtm ac ukconnector:lshtm_ac_uk@1.0.0
descriptionsource · lshtm ac ukconnector:lshtm_ac_uk@1.0.0/metadata/dc/description
publication_datesource · lshtm ac ukconnector:lshtm_ac_uk@1.0.0
titlesource · lshtm ac ukconnector:lshtm_ac_uk@1.0.0/metadata/dc/title